Bone News and Research

RSS

KoACT supplement optimal for bone strength, flexibility in post-menopausal women

Data presented at April's Experimental Biology 2014 Annual Scientific Meeting shows that KoACT, a dietary supplement that combines a proprietary formulation of calcium and collagen is optimal for bone strength and flexibility in post-menopausal women.

8 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Poor nutrition, health cause disparities in fetal growth and newborn size worldwide

Babies' growth in the womb and their size at birth, especially their length, are strikingly similar the world over - when babies are born to healthy, well-educated and well-nourished mothers.

7 Jul 2014

High level of adiponectin linked to decreased risk of diabetes, cardiovascular disease

It has been known for its flavorful addition to soups and as a delicacy for dogs but bone marrow fat may also have untapped health benefits, new research finds.

4 Jul 2014

DFG to establish five new Research Units to pursue current issues in research areas

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing five new Research Units.

4 Jul 2014

Orthopedic surgeon offers critical insights on total knee replacement surgery

In 2010, Bonnie Egbert, a veteran of more than 20 marathons, had to quit running due to excruciating pain caused by her right knee joint rubbing bone on bone.

4 Jul 2014

Discovery points the way to potential new strategies to treat blood disorders

Like a line of falling dominos, a cascade of molecular events in the bone marrow produces high levels of inflammation that disrupt normal blood formation and lead to potentially deadly disorders including leukemia, an Indiana University-led research team has reported.

4 Jul 2014

'Weekend effect' makes simple emergency surgery risky for children

Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children’s Center study.

3 Jul 2014

Achilles wins Cigna's World of Difference grant to explore effect of running on children with autism

A Cigna Foundation grant to Achilles International will help determine whether running holds the key to better mental and physical development for children with autism. The Cigna Foundation today announced its $100,000 World of Difference grant to Achilles International, which has extensive anecdotal evidence showing that walking and running help people on the autism spectrum improve their emotional and physical health.

2 Jul 2014

New way to combat bacterial biofilm formation with titanium encrusted with gold nanoparticles

Bacteria love to colonize surfaces inside your body, but they have a hard time getting past your rugged, salty skin.

1 Jul 2014

Children who undergo simple emergency surgeries on weekends are more likely to die

1 Jul 2014

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA.

1 Jul 2014

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.

From Baxter International Inc. 1 Jul 2014

Vitamin D boost may prevent early death from heart disease and cancer

A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.

1 Jul 2014

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Small Bone Innovations, Inc. (SBi) today announced that Stryker Corporation will acquire substantially all the assets of SBi in an all cash transaction for up to $375 million.

From Stryker 30 Jun 2014

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

30 Jun 2014

Non-surgical gum disease treatment reduces thickness of wall of arteries

A simple non-surgical gum disease treatment markedly reduces the thickness of the wall of the arteries, a risk factor for heart disease, according to a first of its kind study among Aboriginal Australians.

28 Jun 2014

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

28 Jun 2014

Researchers develop new method to target bone growth

In an important development for the health of elderly people, University of Liverpool researchers have developed a new method to target bone growth.

26 Jun 2014

Molecule that blocks bone destruction could provide potential therapeutic target for osteoporosis

UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.

26 Jun 2014

Bone News and Research

KoACT supplement optimal for bone strength, flexibility in post-menopausal women

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Poor nutrition, health cause disparities in fetal growth and newborn size worldwide

High level of adiponectin linked to decreased risk of diabetes, cardiovascular disease

DFG to establish five new Research Units to pursue current issues in research areas

Orthopedic surgeon offers critical insights on total knee replacement surgery

Discovery points the way to potential new strategies to treat blood disorders

'Weekend effect' makes simple emergency surgery risky for children

Achilles wins Cigna's World of Difference grant to explore effect of running on children with autism

New way to combat bacterial biofilm formation with titanium encrusted with gold nanoparticles

Children who undergo simple emergency surgeries on weekends are more likely to die

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

Vitamin D boost may prevent early death from heart disease and cancer

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Non-surgical gum disease treatment reduces thickness of wall of arteries

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Researchers develop new method to target bone growth

Molecule that blocks bone destruction could provide potential therapeutic target for osteoporosis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News